Drug treatment options of high-risk biochemically recurrent prostate cancer based on efficacy and safety: a systematic review and Bayesian network analysis

Drug treatment options of high-risk biochemically recurrent prostate cancer based on efficacy and safety: a systematic review and Bayesian network analysis

Abstract Background Emerging evidence has revealed the potential efficacy of Novel Hormonal Agent (NHA) or chemotherapy in high-risk patients with biochemical recurrence (BCR). However, the optimal drug-based treatment strategy remains unknown. Methods We conducted a comprehensive search of the PubM...

Full description

Saved in:
Bibliographic Details
Main Authors: Qian Wang, Qiyu Zhu, Haoyang Liu, Ke Huang, Xingming Zhang, Jinge Zhao, Hong Zeng, Jindong Dai, Yifu Shi, Hao Zeng, Pengfei Shen
Format: Article
Language:English
Published: BMC 2025-06-01
Series:European Journal of Medical Research
Subjects:
BCR
Efficacy
High risk
Prostate cancer
Safety
Online Access:https://doi.org/10.1186/s40001-025-02643-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items